Feed / DVA

DaVita Inc.

DVA

Healthcare · 175.26 -1.2% today

Isolated · not yet confirmedMarket checked 20 Aug, 15:55 GMT-4

Jodie situation report

DaVita Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 6 directly disclosed connections are confirming.

What changed
  • Revenue increased 6.0% versus the comparable filing period.
Company-1.2% todayVolume comparison unavailable
Market group0 of 7 activeNo Coherent Theme · unavailable
Disclosed network0 of 6 confirmingNo filing-linked name is confirming now
What would change this read
  • Second-quarter U.S. dialysis patient care costs per treatment declined from the first quarter because of seasonal payroll-tax effects, productivity, and lower pharmaceutical costs.
  • Staffing and labor costs have increased during the year, attributed in the filing to the continuation of inflationary conditions.

Invalidation: The isolated read changes if DVA's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind DVA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JYNTFiling-linked namepartnerFeb 11, 2026

" Risk Factors " under the headings " Our business is subject to a complex set of governmental laws, regulations and other requirements...;" "If the number or percentage of patients with higher-paying commercial insurance declines...;" " If we are unable to n…

FMSFresenius Medical Care AGcompetitorFeb 11, 2026

Some competitors, including our largest competitor, Fresenius Medical Care, also manufacture their own supplies and equipment, in addition to owning and operating outpatient dialysis centers worldwide, which may, among other things, provide cost advantages to…

Depended on by

MDTMedtronic plc.partnerJun 18, 2026

This sale was part of an agreement between Medtronic and DaVita to form a new, independent kidney care-focused medical device company (“Mozarc Medical” or "Mozarc") with equal equity ownership.

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

DVA is currently a Follower in the organic co-movement group No Coherent Theme. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for DVA; it is not active in the latest market snapshot.